<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Otrompke, John</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">van Duinkerken, Eelco</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Neurocognitive Decline Unrelated to Mild Cognitive Impairment in Type 1 Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-11</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with type 1 diabetes (T1D) experienced a gradual decline in certain cognitive functions, but the decline was not comparable to mild cognitive impairment, which is a precursor of dementia. The decline in brain volume loss was associated with higher baseline systolic blood pressure, while a decline in executive function was associated with baseline elevated HbA1C in patients with T1D, according to the 4-year follow-up data.</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>